Saltar al contenido principal
Elsevier

Nicotine Use in Mental Illness and Neurological Disorders

  • 1 Edición, Volumen 124 - 19 de octubre de 2015
  • Última edición
  • Editor: Mariella De Biasi
  • Idioma: Inglés

Nicotine Use in Mental Illness and Neurological Disorders, a volume in the International Review of Neurobiology series, is a comprehensive overview of the state-of-the-art… Leer más

Descripción

Nicotine Use in Mental Illness and Neurological Disorders

, a volume in the International Review of Neurobiology series, is a comprehensive overview of the state-of-the-art research into nicotine use in mental illness and neurological disorders. It reviews current knowledge and understanding, also provides a starting point for researchers and practitioners entering the field.

Puntos claves

  • Provides a broad coverage of subject matter
  • Presents a comprehensive overview of the state-of-the-art research into nicotine use in mental illness and neurological disorders
  • Ideal for researchers and practitioners, and those just entering the field

De interès para

People working in basic neuroscience, neurology and psychiatry; medical doctors and care givers.

Índice

  • Preface
  • Part 1: Introductory chapter
    • Chapter One: Neuronal Nicotinic Acetylcholine Receptor Structure and Function and Response to Nicotine
      • Abstract
      • 1 Introduction
      • 2 Nicotinic Receptor Structure
      • 3 Nicotinic Receptor Channel Gating
      • 4 Cationic Permeability of the Nicotinic Receptor Pore
      • 5 Nicotinic Receptor Response to Nicotine from Tobacco
      • 6 Conclusion
      • Acknowledgment
  • Part 2: Schizophrenia
    • Chapter Two: The Role of Nicotine in Schizophrenia
      • Abstract
      • 1 Introduction
      • 2 Effects of Nicotine on Schizophrenia Endophenotypes and Symptom Domains
      • 3 Nicotinic Receptor Genes in Schizophrenia
      • 4 Development of Nicotinic Agents for the Treatment of Schizophrenia
      • 5 Conclusions
    • Chapter Three: Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia
      • Abstract
      • 1 Introduction
      • 2 The α7 nAChRs
      • 3 The Heteromeric α7-Containing Receptors
      • 4 Localization of the α7 Receptors
      • 5 Allosteric Modulation
      • 6 The α7 Receptors in Brain Circuits
      • 7 α7 Receptors and Schizophrenia
      • 8 α7 and NMDA Receptor Interactions in Schizophrenia
      • 9 α7 Receptors as a Drug Target
      • 10 Effects of α7-Selective Compounds on Behavior
      • 11 Conclusions
    • Chapter Four: Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders
      • Abstract
      • 1 Introduction
      • 2 Known Mechanisms of Neuregulin–ErbB Signaling
      • 3 NRG3: Relevance in Smoking Behavior and Co-morbid Disorders
      • 4 ERBB4: Relevance in Smoking Behavior and Co-morbid Disorders
      • 5 Summary
    • Chapter Five: Effective Cessation Strategies for Smokers with Schizophrenia
      • Abstract
      • 1 Efficacy of Bupropion, as Monotherapy or in Combination with NRT
      • 2 Efficacy of Varenicline
      • 3 Duration of Treatment
      • 4 Behavioral Treatment
      • 5 Treatment Adherence
      • 6 Safety Issues
      • 7 Conclusion
  • Part 3: Mood disorders
    • Chapter Six: Role of the Brain's Reward Circuitry in Depression: Transcriptional Mechanisms
      • Abstract
      • 1 Introduction
      • 2 The NAc Reward Circuit in Mood Regulation
      • 3 Transcriptional and Epigenetic Mechanisms in the NAc in Mood Regulation
      • 4 Future Directions
      • Acknowledgment
    • Chapter Seven: Nicotine Addiction and Psychiatric Disorders
      • Abstract
      • 1 Introduction
      • 2 Nicotine's Effects on ADHD
      • 3 Involvement of nAChRs in Anxiety and Anxiety Disorders
      • 4 Effects of Nicotine Dependence, Withdrawal, and nAChR Regulation on Depression
      • 5 Conclusion
      • Acknowledgment
    • Chapter Eight: The Role of Depression in the Uptake and Maintenance of Cigarette Smoking
      • Abstract
      • 1 The Smoking and Depression Problem
      • 2 Adolescent Smoking Uptake and Depression
      • 3 Smoking Cessation and Depression
      • 4 Targeting Positive Mood May Increase Smoking Cessation Treatment Effectiveness
      • 5 Individual Differences in Cessation Outcome and Treatment Effectiveness
      • 6 Conclusions
  • Part 4: Parkinson's disease
    • Chapter Nine: Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement Disorders
      • Abstract
      • 1 Parkinson's Disease Overview
      • 2 Neuroprotection and Parkinson's Disease
      • 3 Nicotine and nAChR Drugs Do Not Improve Parkinsonian Motor Symptoms
      • 4 Nicotine and nAChR Drugs Reduce LIDs
      • 5 Nicotine and nAChR Drugs Reduce Antipsychotic-Induced Tardive Dyskinesias
      • 6 Beneficial Role of Nicotine and nAChR Drugs in Cognition, Depression, and Other Neuropsychiatric Disorders
      • 7 Concluding Remarks
      • Acknowledgment
  • Part 5: Alzheimer's disease
    • Chapter Ten: Nicotinic Cholinergic Mechanisms in Alzheimer's Disease
      • Abstract
      • 1 Homomeric and Heteromeric α7-nAChRs
      • 2 Alterations of α7-nAChR Expressions in AD Animal Models and AD Patients
      • 3 Interaction of Amyloid Beta Peptides (Aβ) and α7-nAChRs
      • 4 Coincident Roles of α7-nAChRs in Aβ Toxicity
      • 5 Roles of α7-nAChRs in Neuronal Hyperexcitation in AD
      • 6 Coincident Roles of α7-nAChRs in AD Pathogenesis
      • 7 Conclusions
  • Index
  • Contents of Recent Volumes

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 124
  • Publicado: 19 de octubre de 2015
  • Idioma: Inglés

Sobre el editor

MD

Mariella De Biasi

Afiliaciones y experiencia
University of Pennsylvania, PA, USA

Ver libro en ScienceDirect

Lee Nicotine Use in Mental Illness and Neurological Disorders en ScienceDirect